LN&Planting (N=53) |
Planting (N=39) |
P-value | |
---|---|---|---|
Age | |||
Mean (SD) | 55.5 (9.75) | 55.3 (11.4) | 0.367 |
Median [Min, Max] | 56.0 [24.0, 79.0] | 54.0 [28.0, 82.0] | |
Operation_history | |||
Direct_surgery | 29 (54.7%) | 30 (76.9%) | 0.0295 |
Septal_tumor_reduction | 0 (0%) | 1 (2.6%) | |
Surgery_after_neoadjuvant | 24 (45.3%) | 8 (20.5%) | |
Type | |||
CCC | 1 (1.9%) | 1 (2.6%) | 0.572 |
EC | 1 (1.9%) | 1 (2.6%) | |
HGSC | 48 (90.6%) | 36 (92.3%) | |
LGSC | 2 (3.8%) | 0 (0%) | |
MC | 0 (0%) | 1 (2.6%) | |
Missing | 1 (1.9%) | 0 (0%) | |
Clinical_stage | |||
I | 0 (0%) | 0 (0%) | NA |
II | 0 (0%) | 7 (17.9%) | |
III | 19 (35.8%) | 24 (61.5%) | |
IV | 34 (64.2%) | 8 (20.5%) | |
Planting_metastasis | |||
No | 0 (0%) | 0 (0%) | NA |
Yes | 53 (100%) | 39 (100%) | |
Lymph.node_metastasis | |||
No | 0 (0%) | 39 (100%) | <0.001 |
Yes | 53 (100%) | 0 (0%) | |
TMB_group | |||
High | 3 (5.7%) | 2 (5.1%) | 1 |
Low | 48 (90.6%) | 37 (94.9%) | |
Missing | 2 (3.8%) | 0 (0%) | |
Relapse_within_6months | |||
Yes | 8 (15.1%) | 4 (10.3%) | 0.514 |
No | 35 (66.0%) | 24 (61.5%) | |
Unknown | 10 (18.9%) | 11 (28.2%) |